Sep 30, 2012

Neurocrine Biosciences Q3 2012 Earnings Report

Total Revenue
$9.36M
Previous year: $41.6M
-77.5%
EPS
-$0.05
Previous year: $0.57
-108.8%
Gross Profit
$9.36M
Previous year: $41.6M
-77.5%
Cash and Equivalents
$44.5M
Previous year: $39.5M
+12.6%
Free Cash Flow
-$8.64M
Previous year: $2.21M
-490.9%
Total Assets
$193M
Previous year: $149M
+29.7%

Neurocrine Biosciences

Neurocrine Biosciences